Edgewise Therapeutics, Inc. (EWTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 509.79M | 543.38M | 573.9M | 603.25M | 443.18M | 475.48M | 499.44M | 519.44M | 541.43M | 327M | 297.92M | 317M |
| Cash & Short-Term Investments | 499.56M | 530.11M | 563.34M | 593.99M | 436.39M | 470.17M | 492.54M | 511.75M | 532.76M | 318.39M | 289.7M | 309.93M |
| Cash Only | 33.21M | 61.15M | 46M | 43.4M | 49.92M | 41.67M | 44.81M | 43.48M | 30.26M | 86.1M | 32.96M | 31.81M |
| Short-Term Investments | 466.35M | 468.96M | 517.34M | 550.59M | 386.47M | 428.5M | 447.73M | 468.27M | 502.5M | 232.3M | 256.74M | 278.12M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 10.23M | 13.28M | 10.56M | 9.26M | 6.79M | 5.31M | 6.9M | 7.69M | 8.67M | 8.6M | 8.22M | 7.07M |
| Total Non-Current Assets | 8.73M | 9.22M | 9.57M | 10.08M | 11.21M | 11.33M | 11.85M | 12.21M | 12.38M | 13.04M | 13.44M | 13.63M |
| Property, Plant & Equipment | 8.73M | 9.22M | 9.57M | 10.08M | 10.52M | 11.07M | 11.58M | 11.94M | 12.38M | 12.69M | 12.98M | 13.21M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 695K | 262K | 262K | 262K | 0 | 348K | 467K | 419K |
| Total Assets | 518.52M | 552.6M | 583.47M | 613.33M | 454.39M | 486.82M | 511.28M | 531.65M | 553.81M | 340.04M | 311.36M | 330.63M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 14.11% | 13.51% | 14.12% | 15.36% | -17.95% | 43.17% | 64.21% | 60.8% | 59.87% | -7.37% | -17.44% | 28.45% |
| Total Current Liabilities | 22.54M | 27.37M | 21.65M | 20.9M | 21.11M | 23.86M | 18.96M | 17.18M | 14.6M | 16.77M | 16.34M | 14.4M |
| Accounts Payable | 7.29M | 6.01M | 6.16M | 8.32M | 8.79M | 5.58M | 5.65M | 6.8M | 4.72M | 4.03M | 5.32M | 3.78M |
| Days Payables Outstanding | 1.01K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.02M | 1.01M | 1.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -988K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 14.23M | 20.35M | 14.48M | 5.94M | 3.97M | 10.06M | 6.18M | 988K | 2.92M | 5.7M | 4.41M | 3.13M |
| Current Ratio | 22.61x | 19.85x | 26.51x | 28.87x | 20.99x | 19.93x | 26.35x | 30.24x | 37.08x | 19.50x | 18.23x | 22.01x |
| Quick Ratio | 22.61x | 19.85x | 26.51x | 28.87x | 20.99x | 19.93x | 26.35x | 30.24x | 37.08x | 19.50x | 18.23x | 22.01x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.78M | 2.98M | 3.17M | 3.37M | 3.56M | 3.74M | 3.45M | 4M | 4.26M | 4.43M | 4.6M | 4.77M |
| Long-Term Debt | 2.78M | 2.98M | 3.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 3.37M | 3.56M | 3.74M | 3.45M | 4M | 4.26M | 4.43M | 4.6M | 4.77M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 25.32M | 30.35M | 24.82M | 24.26M | 24.67M | 27.6M | 22.41M | 21.17M | 18.86M | 21.2M | 20.94M | 19.17M |
| Total Debt | 3.79M | 3.99M | 4.18M | 4.37M | 4.56M | 4.74M | 4.44M | 4.99M | 5.25M | 5.41M | 5.53M | 5.64M |
| Net Debt | -29.42M | -57.16M | -41.82M | -39.03M | -45.36M | -36.93M | -40.37M | -38.5M | -25.02M | -80.68M | -27.43M | -26.16M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 493.2M | 522.26M | 558.65M | 589.07M | 429.72M | 459.22M | 488.88M | 510.47M | 534.94M | 318.83M | 290.43M | 311.45M |
| Equity Growth % | 14.77% | 13.73% | 14.27% | 15.4% | -19.67% | 44.03% | 68.33% | 63.9% | 62.68% | -8.04% | -19.64% | 26.43% |
| Book Value per Share | 4.60 | 5.07 | 5.30 | 5.61 | 4.52 | 4.97 | 5.21 | 5.46 | 6.11 | 4.92 | 4.58 | 4.91 |
| Total Shareholders' Equity | 493.2M | 522.26M | 558.65M | 589.07M | 429.72M | 459.22M | 488.88M | 510.47M | 534.94M | 318.83M | 290.43M | 311.45M |
| Common Stock | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 9K | 7K | 6K | 6K |
| Retained Earnings | -595.38M | -546.37M | -496.15M | -455.49M | -419.37M | -378.58M | -338.91M | -304.79M | -273.29M | -244.76M | -214.62M | -188.91M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -252K | 677K | 701K | 204K | 401K | 420K | 1.05M | -1.05M | -861K | 99K | -424K | -547K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |